Hannah Brendan (CIK 1929422) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-12-08). Recent activity: Buy QNCX (2,271 shares), Buy QNCX (25,280 shares), Buy QNCX (37,736 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-08 | Quince Therapeutics, Inc. (QNCX) | CBO, COO & CCO | Buy | 2,271 | $1,249 |
| 2025-12-08 | Quince Therapeutics, Inc. (QNCX) | CBO, COO & CCO | Buy | 25,280 | $23,763 |
| 2025-06-23 | Quince Therapeutics, Inc. (QNCX) | CBO, COO & CCO | Buy | 37,736 | $45,283 |
Source: SEC Form 4 filings · as of 2025-12-08